icr.ac.uk3d
The Adult Drug Development Unit at the ICR and the RM
The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...
icr.ac.uk4d
Unlocking the potential of protein degradation in cancer research
Dr Agnieszka Konopacka recently joined The Institute of Cancer Research, London, as Group Leader of the Induced Proximity Therapeutics Group, which sits within the Centre for Protein Degradation in ...
icr.ac.uk4d
Blood cancer patients should be offered genetic testing to spot ‘double hit’ high-risk cases earlier
Offering genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, ...
icr.ac.uk6d
Newly identified therapeutic target may lead to effective treatments for the most common and dangerous form of brain cancer
Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma, a common type of adult brain tumour, rely on a specific enzyme for survival and that inhibiting ...